BioCentury
ARTICLE | Company News

Link Health, Wilex deal

April 7, 2014 7:00 AM UTC

Wilex granted Link Health exclusive rights to develop and commercialize Mesupron in Taiwan and China, including Hong Kong and Macau, for all cancer indications. Wilex is eligible for an upfront payme...